Contiguous Stage II Marginal Zone Lymphoma Completed Phase 0 Trials for Busulfan (DB01008)

IndicationStatusPhase
DBCOND0029471 (Contiguous Stage II Marginal Zone Lymphoma)Completed0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01959477Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell TransplantTreatment